(5Z,8ξ,13E,15R)-9,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid (59894-05-2)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (5Z,13E,15S)-11α,15-Dihydroxy-11-methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,11alpha,13E,15R)-15-(Acetyloxy)-11,16,16-tri- methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15R,16R)-16-fluoro-15-hydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15S)-9α,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid 1,9-lactone
- (5Z,13E,15S)-9α,15-Dihydroxy-11-oxoprosta-5,13-dien-1-oic acid 1,15-lactone
- (5Z,13E,15S)-9α,15-Dihydroxy-16,16-dimethyl-11-oxoprosta-5,13-dien-1-oic acid
- (5Z,9α,13E)-9-Hydroxy-11-methylene-15-oxoprosta-5,13-dien-1-oic a cid
- (5Z,13E,15S)-15-Hydroxy-15-methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E)-15-hydroxy-15-methyl-9-oxoprosta-5,13-dien-1-oic acid
- (5Z,13E,15S)-15-Hydroxy-9-oxoprosta-5,8(12),13-trien-1-oic acid methyl ester
- (5Z,11alpha,13E,15S)-11,15-dihydroxy-16,16-dimethyl-9-oxoprosta-5,13-dien-1-oic acid
- Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-15-methyl-9-oxo-, methyl ester, (5Z,11alpha,13E,15R)-
- (5Z,13E,15S)-15-hydroxy-15-methyl-11-oxoprosta-5,9,13-trien-1-oic acid
- (5Z,13E,15S,17Z)-15-Hydroxy-9-oxoprosta-5,11,13,17-tetraen-1-oic acid
- (5Z,8β,13E,15S)-15-Hydroxy-9-oxoprosta-5,10,13-trien-1-oic acid
- (5Z,11alpha,13E,15S,19R)-11,15,19-trihydroxy-9-oxoprosta-5,13-dien-1-oic acid
- (13E,15S)-15-Hydroxy-9-oxoprosta-11,13-dien-1-oic acid
- (2E,11alpha,13E,15S)-17-ethyl-11,15-dihydroxy-9-oxoprosta-2,13-dien-1-oic acid
- (2E,11α,13E,15S,17R)-11,15-Dihydroxy-17,20-diMethyl-
9-oxoprosta-2,13-dien-1-oic Acid
- (5Z,9alpha,11alpha,13E,15S)-6,9-Epoxy-11,15-dihydroxy-7-oxoprosta-5,13-dien-1-oic acid monosodium salt